Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013401 · ClinicalTrials.gov registry record
Transmission of Mother-Infant Stress Communication
A clinical trial, sponsored by University of Massachusetts, Boston.
- Completed
- Registry status
- 56
- Enrollment target
NCT02013401: Completed study, sponsored by University of Massachusetts, Boston.
NCT02013401 is a clinical trial that has completed, run by University of Massachusetts, Boston. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02013401 has completed, sponsored by University of Massachusetts, Boston.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The central aim of this study is to assess mother-infant communication via behavioral, physiological, and affective indices under conditions where distal stressors may not be directly detectable by the infant.
Primary Outcome
Salivary cortisol is a measure that indicates hypothalamus-pituitary-adrenal axis activity. The study obtains 4 assessments with 20 minutes between each assessment. Participants chew on a cotton role for 2-minutes which is placed in a cortisol salivette tube (Sarstedt)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-07-14 |
What the finished NCT02013401 record still lists
NCT02013401 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02013401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02013401 about?
NCT02013401 is a clinical study titled "Transmission of Mother-Infant Stress Communication". The central aim of this study is to assess mother-infant communication via behavioral, physiological, and affective indices under conditions where distal stressors may not be directly detectable by the infant.
What is the current status of trial NCT02013401?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2013-10. Estimated completion is 2016-07-14.
Who is sponsoring clinical trial NCT02013401?
This trial is sponsored by University of Massachusetts, Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia